BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3907243)

  • 1. [Bone marrow transplantation in children. II. Immunologic aspects].
    Muranaka S; Kato S; Arimori S; Nose Y; Yamamura M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1176-86. PubMed ID: 3907243
    [No Abstract]   [Full Text] [Related]  

  • 2. [NK and K cell activity in children with leukemias and aplastic anemias before and after allogeneic bone marrow transplantation].
    Thränhardt H; Prager J; Fuchs D; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):285-92. PubMed ID: 2410337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow transplantation in leukemia and aplastic anemia: experience with 40 patients].
    Volin L; Rajantie J; Perkkiö M; Elonen E; Saarinen U; Remes K; Hovi L; Ruutu P; Ruutu T; Siimes MA
    Duodecim; 1984; 100(20):1305-12. PubMed ID: 6391895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone marrow transplantation in children. I. Clinical aspects].
    Kato S; Hoshi N; Muranaka S; Kimura M; Nagao T; Watanabe K; Mori T; Tamaoki N; Hata J; Tsuji K
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1168-75. PubMed ID: 3907242
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone marrow transplantation for aplastic anemia and acute leukemia (author's transl)].
    Nakamura S
    Rinsho Ketsueki; 1980 Apr; 21(4):465-71. PubMed ID: 6997546
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic resistance to bone marrow transplantation as a leukemia-lymphoma defense mechanism: correlation of "in vivo" lymphoma resistance and "in vitro" NK activity.
    Gallagher MT; Datta SK; Trentin JJ
    Biomedicine; 1980 May; 33(3):73-5. PubMed ID: 7004513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS; Storb R; Weiden PL; Thomas ED
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.
    Trigg ME; Sondel PM; Billing R; Finlay JL; Peterson A; Hong R; Frierdich S; Shahidi N
    J Biol Response Mod; 1985 Dec; 4(6):602-12. PubMed ID: 3910764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immunology in the treatment of leukemias and hematosarcomas.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
    Cancer Res; 1967 Dec; 27(12):2542-53. PubMed ID: 4170385
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current possibilities for the clinical transplantation of hematopoietic tissue].
    Chertkov IL
    Klin Med (Mosk); 1975 May; 52(5):28-34. PubMed ID: 237137
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation in children.
    Dooren LJ; Kamphuis RP; de Koning J; Vossen JM
    Semin Hematol; 1974 Jul; 11(3):369-82. PubMed ID: 4599790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cell-mediated and humoral immunity in lymphoreticular proliferative diseases at various clinical stages].
    Traczyk Z; Litwin J; Cieśluk S; Weiner B
    Pol Tyg Lek; 1974 May; 29(19):805-7. PubMed ID: 4848215
    [No Abstract]   [Full Text] [Related]  

  • 13. Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation.
    Neiman P; Wasserman PB; Wentworth BB; Kao GF; Lerner KG; Storb R; Buckner CD; Clift RA; Fefer A; Fass L; Glucksberg H; Thomas ED
    Transplantation; 1973 May; 15(5):478-85. PubMed ID: 4351024
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
    Livnat S; Seigneuret M; Storb R; Prentice RL
    J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreconstitution after human bone marrow transplantation.
    Zintl F; Prager J; Sauerbrey A; Metzner G; Hermann J; Fuchs D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):519-26. PubMed ID: 2480301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis.
    Elfenbein GJ; Anderson PN; Humphrey RL; Mullins GM; Sensenbrenner LL; Wands JR; Santos GW
    Transplant Proc; 1976 Dec; 8(4):641-6. PubMed ID: 136774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone marrow transplantation in blood diseases and neoplasms].
    Robak T
    Postepy Hig Med Dosw; 1985; 39(5):465-517. PubMed ID: 3915351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone marrow transplantation. Indications in adult patients with leukemia or aplastic anemia].
    Evensen SA; Frøland SS; Stavem P; Albrechtsen D; Flatmark A
    Tidsskr Nor Laegeforen; 1984 Aug; 104(23):1542-4. PubMed ID: 6385336
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications, problems and future perspectives of bone marrow transplantation in pediatrics].
    Slavc I
    Padiatr Padol; 1992; 27(6):167-75. PubMed ID: 1484709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Group for Blood and Marrow Transplantation (EBMT): a report from the president and the chairmen of the working parties.
    Gratwohl A; Gorin C; Apperley J; Goldstone A; Rosti G; Bacigalupo A; Gluckman E; Fischer A; Ljungman P; Kolb HJ; Niethammer D
    Bone Marrow Transplant; 1996 Oct; 18(4):677-91. PubMed ID: 8899181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.